[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353481-105":59,"doc-detail-353481-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","androgen-receptor-drives-divergent-chromatin-accessibility-programs-in-benign-and-malignant-prostate-epithelial-cells","Androgen receptor drives divergent chromatin accessibility programs in benign and malignant prostate epithelial cells","","Androgen receptor (AR) activation reshapes chromatin structure in prostate cancer cells, yet its behavior in nonmalignant prostate epithelial cells remained insufficiently defined. Using established NPEC (RWPE-1-AR and RWPE-1-Ctrl) and PC (LNCaP-pcDNA3.1 and LNCaP-ARhi) models, androgen-driven chromatin responses were mapped by ATAC-seq. Baseline accessibility differed broadly between cell types, and androgen stimulation further amplified distinct AR-mediated remodeling. Clinical ATAC-seq comparison supported model relevance. Integrated ATAC-seq and mRNA-seq revealed model-specific AR targets, including CDKN1C/p57 in NPEC.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/androgen-receptor-drives-divergent-chromatin-accessibility-programs-in-benign-and-malignant-prostate-epithelial-cells/353481/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/androgen-receptor-drives-divergent-chromatin-accessibility-programs-in-benign-and-malignant-prostate-epithelial-cells/353481.png","ImageObject",300,407,{"name":92,"@type":93},"moss~","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"How did the study profile androgen-driven chromatin responses?","Question",{"text":113,"@type":114},"It used ATAC-seq to map chromatin accessibility changes after androgen stimulation in established NPEC and prostate cancer cell models.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What did baseline chromatin accessibility show between nonmalignant and cancer cells?",{"text":118,"@type":114},"In the absence of androgen, both NPEC and PC cells exhibited widespread differences in chromatin accessibility.",{"name":120,"@type":111,"acceptedAnswer":121},"How were model relevance and AR target genes validated?",{"text":122,"@type":114},"Clinical-sample ATAC-seq profiles were used to compare similarity, and integration of ATAC-seq with mRNA-seq identified model-specific AR target genes such as CDKN1C/p57 in NPEC.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},353481,1790186833,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},962090895452,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Androgen receptor drives divergent chromatin accessibility programs in benign and malignant prostate epithelial cells  \nKonsta Kukkonen 1 , Ebrahim Afyounian 1 , Hanna Rauhala 1 , Matti Nykter 1 , Alfonso Urbanucci 1,2,3, Leena Latonen 4 , Tapio Visakorpi 1,5 ,*  \n1 Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere University Hospital, 33520 Tampere, Finland  \n2 Foundation for the Finnish Cancer Institute, 00290 Helsinki, Finland  \n3 Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, 0424 Oslo, Norway  \n4 Institute of Biomedicine, University of Eastern Finland, 70211 Kuopio, Finland  \n5 Fimlab Laboratories Ltd, Tampere University Hospital, 33520 Tampere, Finland  \n∗[To whom correspondence should be addressed. Email:](To whom correspondence should be addressed. Email: tapio.visakorpi@tuni.fi)[ tapio.visakorpi@tuni.fi](To whom correspondence should be addressed. Email: tapio.visakorpi@tuni.fi)  \nAbstract  \nAndrogen receptor (AR) activation alters chromatin structure in prostate cancer (PC) cells, but its impact in nonmalignant prostate epithelial cells (NPEC) remains poorly characterized due to lack of representative models. We leveraged our previously established NPEC (RWPE-1-AR and RWPE-1-Ctrl) and PC (LNCaP-pcDNA3 .1 and LNCaP-ARhi) cell models to profile androgen-driven chromatin responses using assay for transposase-accessible chromatin with sequencing (ATAC-seq) . In the absence of androgen, NPEC and PC cells exhibited widespread differences in chromatin accessibility. Androgen stimulation amplified these differences, revealing distinct AR-mediated chromatin remodeling between the cell types. Androgen-sensitive regions were enriched for nuclear receptor binding sites (AR and glucocorticoid receptor), with AP-1 motifs more prominent in NPEC and FOXA1 motifs in PC cells.  \nComparison with ATAC-seq profiles obtained from clinical samples showed that NPECs resembled benign prostate hyperplasia, while PC cells mirrored untreated and castration-resistant PC, supporting the relevance of our models. Integration of ATAC-seq and mRNA-sequencing (mRNAseq) identified model-specific AR target genes, including CDKN1C/p57 in NPEC, which may contribute to the previously observed androgeninduced growth arrest in these cells. These findings demonstrate that AR activation reprograms chromatin accessibility in normal prostate epithelium, revealing fundamental regulatory differences compared to the tumor context and underscore the importance of physiologically relevant cell models.  \nGraphical abstract  \nAndrogen regulated  \nDHT  \nDHT  \ngene expression  \nDHT  \nAR  \nDHT  \nAR  \nHsp  \nHsp  \nGrowth  Differentiation  \nGrowth  Survival   \nIntroduction  \nProstate cancer (PC) is the most common cancer in men in countries with Western lifestyle and the incidence is projected to more than double by 2040 [1, 2] . Despite extensive efforts in characterization of PC biology, targeting the androgen  \nreceptor (AR) signaling with androgen deprivation therapy remains the most effective therapeutic option for advanced disease. AR is a nuclear receptor, which translocates to the nucleus upon binding its ligand, dihydrotestosterone (DHT), and regulates the expression of specific target genes. AR  \nReceived: November 24, 2025. Revised: June 24, 2026. Accepted: July 21, 2026 © The Author(s) 2026 . Published by Oxford University Press.  \nThis is an Open Access article distributed under the terms of the Creative Commons Attribution License ([https://creativecommons.org/licenses/by/4.0/](https://creativecommons.org/licenses/by/4.0/)), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.  \n2 Kukkonen et al.  \nsignaling inhibitors such as enzalutamide and abiraterone acetate have improved patient survival [3, 4], but resistance eventually emerges through mechanisms similar to those observed for old generation AR-targeti","cbCairr7FzEjf96n","https://ap.wps.com/l/cbCairr7FzEjf96n","pdf",3222691,15,"English","# Abstract\n# Graphical abstract\n# Introduction\n# Materials and methods","[{\"question\":\"How did the study profile androgen-driven chromatin responses?\",\"answer\":\"It used ATAC-seq to map chromatin accessibility changes after androgen stimulation in established NPEC and prostate cancer cell models.\"},{\"question\":\"What did baseline chromatin accessibility show between nonmalignant and cancer cells?\",\"answer\":\"In the absence of androgen, both NPEC and PC cells exhibited widespread differences in chromatin accessibility.\"},{\"question\":\"How were model relevance and AR target genes validated?\",\"answer\":\"Clinical-sample ATAC-seq profiles were used to compare similarity, and integration of ATAC-seq with mRNA-seq identified model-specific AR target genes such as CDKN1C/p57 in NPEC.\"}]","Androgen receptor drives divergent chromatin accessibility programs in benign and malignant prostate epithelial cells | PDF",1790105649,38,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/16c2759bf378aed2841f9bab7303652c.webp",983,1272,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8a236f8a2b21026e82124782b2c2ee93.webp",982,1270,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9d290d9888101a549d6cc6d8be24a362.webp",981,1269,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f349e601879af1b4a7a6ae3ed9f2761f.webp",980,1268]